| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q1 2020 Pre-Market | EPS: REV: | 0.81 81.204M | |||
| Q4 2019 Pre-Market | EPS: REV: | 1.16 75.603M | |||
| Q3 2019 Pre-Market | EPS: REV: | 0.32 67.39M | |||
| Q2 2019 Pre-Market | EPS: REV: | 1.36 66.953M | |||
| Q1 2019 Pre-Market | EPS: REV: | 2.9 103.274M | 80.8M | 0.81 81.204M | 0.5% |
| Q4 2018 Pre-Market | EPS: REV: | 3.16 103.675M | 0.12 72.4M | 1.16 75.603M | 866.67% 4.42% |
| Q3 2018 Pre-Market | EPS: REV: | 2.35 89.366M | 0.39 74.5M | 0.32 67.39M | -17.95% -9.54% |
| Q2 2018 Pre-Market | EPS: REV: | 1.29 76.002M | 0.94 62.7M | 1.36 66.953M | 44.68% 6.78% |
| Q1 2018 Pre-Market | EPS: REV: | 2.32 83.808M | 2.26 94.3M | 2.9 103.274M | 28.32% 9.52% |
| Q4 2017 Pre-Market | EPS: REV: | 0.58 46.116M | 1.84 90.85M | 3.16 103.675M | 71.74% 14.12% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Earnings Scheduled For June 17, 2019
- Analysts: Broadcom's Reduced Outlook Due More To Caution Than Broader Weakness
- Chip Stocks Fall In Sympathy With Broadcom After Q2 Sales Miss, Guidance Cut
- The Daily Biotech Pulse: Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA
- 5 Stocks To Watch For June 14, 2019